Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
BBVA Argentina
BBAR
$3.26B
| $809K | ﹤0.01% |
215,800
-85,691
| -28% | -$280K |
|
|
UNIT
2652
Uniti Group
UNIT
$2.41B
| $809K | ﹤0.01% |
+86,486
| New | +$649K |
|
|
SECO
2653
DELISTED
Secoo Holding Limited ADR
SECO
| $808K | ﹤0.01% |
25,020
+14,670
| +142% | +$421K |
|
2654
Amplify Cybersecurity ETF
HACK
$3.01B
| $805K | ﹤0.01% |
+18,100
| New | +$751K |
|
2655
Lifecore Biomedical
LFCR
$177M
| $805K | ﹤0.01% |
101,100
+82,800
| +452% | +$854K |
|
2656
Turkcell
TKC
$4.68B
| $801K | ﹤0.01% |
+139,019
| New | +$709K |
|
|
WINS
2657
DELISTED
Wins Finance Holdings Inc. Ordinary Shares (Cayman Islands)
WINS
| $800K | ﹤0.01% |
20,200
+2,300
| +13% | +$35.9K |
|
|
BGMS
2658
Bio Green Med Solution Inc
BGMS
$4.92M
| $798K | ﹤0.01% |
48
+30
| +167% | +$559K |
|
|
JE
2659
DELISTED
Just Energy Group Inc
JE
| $798K | ﹤0.01% |
47,031
-22,623
| -32% | -$364K |
|
|
CIZN
2660
DELISTED
Citizens Holding Co.
CIZN
| $798K | ﹤0.01% |
31,912
+9,311
| +41% | +$209K |
|
|
CFRX
2661
DELISTED
ContraFect Corporation
CFRX
| $797K | ﹤0.01% |
1,560
+724
| +87% | +$355K |
|
|
EVOL
2662
DELISTED
Evolving Systems, Inc.
EVOL
| $796K | ﹤0.01% |
736,936
+14,221
| +2% | +$13.6K |
|
2663
First Trust Capital Strength ETF
FTCS
$8.01B
| $795K | ﹤0.01% |
13,600
+1,100
| +9% | +$61.5K |
|
|
TREC
2664
DELISTED
Trecora Resources
TREC
| $795K | ﹤0.01% |
126,749
+24,364
| +24% | +$136K |
|
2665
Acushnet Holdings
GOLF
$5.27B
| $793K | ﹤0.01% |
22,800
-71,200
| -76% | -$2.11M |
|
2666
Oramed Pharmaceuticals
ORMP
$180M
| $792K | ﹤0.01% |
224,315
+35,900
| +19% | +$120K |
|
|
EVFM
2667
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $788K | ﹤0.01% |
18,574
+17,627
| +1,861% | +$1.19M |
|
2668
LeMaitre Vascular
LMAT
$1.88B
| $787K | ﹤0.01% |
29,800
-14,000
| -32% | -$366K |
|
|
GDP
2669
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $783K | ﹤0.01% |
108,800
-22,000
| -17% | -$155K |
|
|
TRT
2670
Trio-Tech International
TRT
$118M
| $782K | ﹤0.01% |
499,960
-10,800
| -2% | -$15.6K |
|
2671
NLI Holdings
NL
$319M
| $781K | ﹤0.01% |
229,114
+5,600
| +3% | +$17.4K |
|
|
RYZ
2672
Ryerson Holding Corp
RYZ
$1.51B
| $781K | ﹤0.01% |
138,700
-96,829
| -41% | -$479K |
|
2673
Warner Bros
WBD
$69.6B
| $781K | ﹤0.01% |
37,000
-81,400
| -69% | -$1.76M |
|
|
WSTL
2674
DELISTED
Westell Technologies Inc
WSTL
| $781K | ﹤0.01% |
953,981
+47,211
| +5% | +$37.9K |
|
|
STRR
2675
Star Equity Holdings
STRR
$39.4M
| $780K | ﹤0.01% |
88,596
+5,800
| +7% | +$52.5K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.